Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of BI 3000202 with Itraconazole and Ciclosporin in Healthy Males
NCT07774325Phase 1Active, not recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of BI 3000202 (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve from zero extrapolated to infinity up to 4 days and Maximum measured concentration up to 4 days. Started Sep 2026; status: active, not recruiting.
02
Drugs
BI 3000202
Beyond the preview
Go deeper on NCT07774325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07774325.